![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SeekIn Cancer Recurrence Monitoring Kit Gains CE-IVD Mark
SeekIn Cancer Recurrence Monitoring Kit Gains CE-IVD Mark
SeekIn received the CE-IVD mark for its SeekInCure cancer recurrence monitoring kit, which tests for minimal residual disease (MRD) — an indicator of possible recurrence.
The test looks for cancer genome alterations in cell-free DNA — degraded DNA tumor cell fragments that are released into the bloodstream — and identifies patients who are more likely to relapse as well as lower-risk patients who can then avoid unnecessary follow-up treatment.
The test can be performed within a month of radical surgery, a procedure in which a tumor and a large amount of tissue are removed.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct